List of bibliographic references
Number of relevant bibliographic references: 3.
List of associated KwdEn.i
Nombre de documents | Descripteur |
3 | Rheumatology |
2 | Adalimumab |
2 | American college |
2 | Arthritis |
2 | Arthritis rheum |
2 | Monoclonal antibody |
2 | Rheum |
2 | Rheumatoid arthritis |
1 | ACR, American College of Rheumatology |
1 | ANA, antinuclear antibody |
1 | Abbott laboratories |
1 | Adalimumab monotherapy |
1 | Adalimumab treatment groups |
1 | Adverse event |
1 | Adverse events |
1 | Antinuclear antibodies |
1 | Antirheumatic drugs |
1 | Arthritis rheum bodolay |
1 | Arthritis rheum cutolo |
1 | Atkins |
1 | Available datasets |
1 | Baseline |
1 | Baseline value |
1 | CRP, C reactive protein |
1 | Capillaroscopic |
1 | Capillaroscopic pattern |
1 | Chronic |
1 | Classification criteria |
1 | Clin |
1 | Concomitant |
1 | Concomitant methotrexate |
1 | Connective |
1 | Connective tissue disease |
1 | Critical importance |
1 | DAS, disease activity score |
1 | DMARDs, disease modifying antirheumatic drugs |
1 | Delphi technique |
1 | Diagnostic criteria |
1 | Diffuse cutaneous |
1 | Disability index |
1 | Disease activity |
1 | Disease activity score |
1 | Disease evolution |
1 | Dmard |
1 | Dmards |
1 | Dos |
1 | Drug |
1 | ESR, erythrocyte sedimentation rate |
1 | EULAR, European League Against Rheumatism |
1 | Earliest phase |
1 | Early diagnosis |
1 | Early disease |
1 | Early treatment |
1 | Effective drugs |
1 | Erythrocyte sedimentation rate |
1 | Eular |
1 | Eular response |
1 | Eular response rates |
1 | Eular scleroderma trial |
1 | European league |
1 | Good eular response |
1 | Gordian knot |
1 | HAQ DI, Disability Index of the Health Assessment Questionnaire |
1 | Health assessment questionnaire |
1 | Human |
1 | Injection site reaction |
1 | Internal medicine |
1 | Limit patient evaluation |
1 | Limited cutaneous |
1 | MTX, methotrexate |
1 | Matucci cerinic |
1 | Mctd |
1 | Methotrexate |
1 | Monoclonal |
1 | Monotherapy |
1 | NSAIDs, non-steroidal anti-inflammatory drugs |
1 | Other week |
1 | Patient assessment |
1 | Percentage change |
1 | Placebo |
1 | Predictor |
1 | Preliminary criteria |
1 | Previous dmard treatment |
1 | Primary efficacy |
1 | Primary phenomenon |
1 | Prospective studies |
1 | Provisional criteria |
1 | Puffy fingers |
1 | Putte |
1 | RA, rheumatoid arthritis |
1 | Randomised |
1 | Reactive protein |
1 | Regimen |
1 | Reliable predictors |
1 | Research group |
1 | Respective adalimumab doses |
1 | Response criteria |
1 | Response rates |
1 | Rheumatoid |
1 | Rheumatol |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "P. Nash"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "P. Nash" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= P. Nash
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | |